Sitemap

Trisha Pillay

Closing the Innovation Gap: Why Drug Discovery Breakthroughs Are Failing to Reach Patients

Why do so many drug discovery breakthroughs fail to reach patients? Trisha Pillay speaks with Christian Nkanga to find out.

Responsible AI that Redefines Clinical Trials

Best Practices for Clinical Data Managers

The State of AI In Clinical Trials 2026: Annual Report

Insights from clinical operations leaders show where AI is delivering, what's holding the industry back, and why early adopters are pulling ahead.

Nicole Dale

Anthropic’s Big AI Drug Discovery Announcement

Anthropic drug discovery programme combines AI research with pharmaceutical R&D as a scientist uses advanced analytics to accelerate neglected disease drug discovery.

Anthropic's new drug discovery programme marks a strategic shift from sole AI software provider to active R&D participant. Here's what it means for pharmaceutical innovation.

Nicole Dale

Anthropic’s Gates Foundation Partnership and Healthcare AI

Pharmatica image of a glass globe illuminated from within by bright yellow light, surrounded by blue data lines, symbolising AI bringing light, intelligence, and innovation to global healthcare through the Anthropic and Gates Foundation Partnership.

See how Anthropic's Gates Foundation partnership and Long-Term Benefit Trust could lead the way in shaping responsible AI governance across healthcare innovation.

Nicole Dale

AI in Healthcare: OpenAI and Epic Integration Connects EHRs

Pharmatica image showing a healthcare professional using AI in healthcare connecting OpenAI and Epic electronic health records through an integrated clinical data platform.

OpenAI and Epic integration brings AI healthcare into EHR workflows, connecting patient records with ChatGPT for Healthcare to advance research and patient care.

Shahid Siddiqui

Founder and CEO, McGenome, LLC

Therapeutic Drug Discovery

Deepankar Nayak

CEO, Deep Longevity, London, UK

HealthTech & AI

Kimberly S. Clarke

Scientific Council Member – Anchor, Oncology & Advanced Therapeutics

Clinical Development

Dr. Claus Bolte

Director and Vice-Chair of committees at University Hospital Basel

Regulatory & Commercialisation

Claudia Matheny

Technical Operations

HealthTech & AI

Founded in 2004, Ametris (formerly ActiGraph) is a global digital health solutions provider transforming real-world patient data into validated clinical evidence. Our end-to-end platform combines advanced wearables, regulatory-aligned analytics, and expert scientific support across every phase of a clinical trial. We serve leading pharmaceutical, biotech, and public health research organizations worldwide, backed by two decades of experience and a collaborative, science-first approach.In 2026, Ametris joined Signant Health, uniting wearable-derived digital outcome measures with industry-leading eCOA solutions to give sponsors a single partner for integrated evidence generation, combining continuous sensor data with patient-reported outcomes.

Clinical Development

<a href="https://www.medidata.com/en/">Medidata </a>has been powering smarter treatments and healthier people by supporting clinical trials through groundbreaking technological innovations for over 25 years. Medidata is a leader in AI-powered solutions across the entire trial lifecycle to accelerate clinical breakthroughs, reduce patient and site burden, and bring new therapies to market faster. Supported by one of the largest clinical datasets in the industry of more than 38,000 trials and 12 million patients, Medidata's <a href="https://www.medidata.com/en/experiences/study-experience/">Study</a>, <a href="https://www.medidata.com/en/experiences/patient-experience/">Patient</a>, and <a href="https://www.medidata.com/en/experiences/data-experience/">Data</a> Experiences are trusted by more than 1 million registered users across approximately 2,300 customers. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and is recognized as a leader by Everest Group and IDC. Discover more at <a href="https://www.medidata.com/">www.medidata.com</a>. Listen to our latest podcast, <a href="https://www.medidata.com/en/from-dreamers-to-disruptors-podcast/">from Dreamers to Disruptors</a>, and follow us at @medidata-solutions on LinkedIn.

Clinical Development

Caidya is a global, therapeutically focused drug development partner helping biotech and biopharma sponsors make smarter decisions, move faster, and advance together. Our connected teams combine scientific insight, operational expertise, and local knowledge across critical markets to generate actionable evidence and keep complex development programs moving forward.